124 related articles for article (PubMed ID: 32740010)
21. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
22. Conjunctival nevi clinical features and therapeutic outcomes.
Levecq L; De Potter P; Jamart J
Ophthalmology; 2010 Jan; 117(1):35-40. PubMed ID: 19896191
[TBL] [Abstract][Full Text] [Related]
23. Comparison of posterior lamellar resection versus lumpectomy for initial management of localized tarsal conjunctival sebaceous carcinoma in 54 cases.
Lally SE; Rao R; Shields JA; Shields CL
Indian J Ophthalmol; 2018 Sep; 66(9):1295-1300. PubMed ID: 30127144
[TBL] [Abstract][Full Text] [Related]
24. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases.
De Potter P; Shields CL; Shields JA; Menduke H
Br J Ophthalmol; 1993 Oct; 77(10):624-30. PubMed ID: 8218029
[TBL] [Abstract][Full Text] [Related]
25. Proton radiotherapy in advanced malignant melanoma of the conjunctiva.
Scholz SL; HĂ©rault J; Stang A; Griewank KG; Meller D; Thariat J; Steuhl KP; Westekemper H; Sauerwein W
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1309-1318. PubMed ID: 30919076
[TBL] [Abstract][Full Text] [Related]
26. Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.
Wuestemeyer H; Sauerwein W; Meller D; Chauvel P; Schueler A; Steuhl KP; Bornfeld N; Anastassiou G
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):438-46. PubMed ID: 16133022
[TBL] [Abstract][Full Text] [Related]
27. Conjunctival papilloma: features and outcomes based on age at initial examination.
Kaliki S; Arepalli S; Shields CL; Klein K; Sun H; Hysenj E; Lally SE; Shields JA
JAMA Ophthalmol; 2013 May; 131(5):585-93. PubMed ID: 23538642
[TBL] [Abstract][Full Text] [Related]
28. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
29. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
Esmaeli B; Wang X; Youssef A; Gershenwald JE
Ophthalmology; 2001 Nov; 108(11):2101-5. PubMed ID: 11713086
[TBL] [Abstract][Full Text] [Related]
30. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes.
Arepalli S; Kaliki S; Shields CL; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):691-6. PubMed ID: 24557333
[TBL] [Abstract][Full Text] [Related]
31. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
32. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
Tuomaala S; Kivelä T
Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
[TBL] [Abstract][Full Text] [Related]
33. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center.
Vaidya S; Dalvin LA; Yaghy A; Pacheco R; Shields JA; Lally SE; Shields CL
Eur J Ophthalmol; 2021 Sep; 31(5):2675-2685. PubMed ID: 33176471
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.
Yousef YA; Finger PT
Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846
[TBL] [Abstract][Full Text] [Related]
36. American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract][Full Text] [Related]
37. Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.
Shields CL; Sioufi K; Srinivasan A; Di Nicola M; Masoomian B; Barna LE; Bekerman VP; Say EAT; Mashayekhi A; Emrich J; Komarnicky L; Shields JA
JAMA Ophthalmol; 2018 Dec; 136(12):1325-1333. PubMed ID: 30267070
[TBL] [Abstract][Full Text] [Related]
38. Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: a long-term study.
Dalla Pozza G; Ghirlando A; Busato F; Midena E
Eur J Ophthalmol; 2005; 15(4):446-50. PubMed ID: 16001375
[TBL] [Abstract][Full Text] [Related]
39. Conjunctival melanoma: Insights into classification, outcomes, and biomarkers.
Shields CL; Silva AMV; Laiton A; Kalafatis NE; Schiller E; Lally SE; Grant-Kels JM; Shields JA
Clin Dermatol; 2024; 42(1):46-55. PubMed ID: 37858779
[TBL] [Abstract][Full Text] [Related]
40. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control.
Mashayekhi A; Shields CL; Rishi P; Atalay HT; Pellegrini M; McLaughlin JP; Patrick KA; Morton SJ; Remmer MH; Parendo A; Schlitt MA; Shields JA
Ophthalmology; 2015 Mar; 122(3):600-9. PubMed ID: 25439431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]